Verseon
Pre-clinicalVerseon is the world's most advanced drug design & development platform. We change the standard of care for every disease we address.
Founded
2002
Focus
Small Molecules
About
Verseon is the world's most advanced drug design & development platform. We change the standard of care for every disease we address.
Funding History
3Total raised: $70M
Series C$30MUndisclosedJun 15, 2019
Series B$25MUndisclosedJun 15, 2017
Series A$15MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2002
LocationFremont, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile